文献速递胸部神经CT

基于CT的影像组学模型预测T1期肺腺癌脑转移

CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma.
PubMed 文献 · AJR Am J Roentgenol · 2019-04-01

本研究纳入89例T1期肺腺癌患者(脑转移35例、无脑转移54例),从平扫CT提取1160个影像组学特征,构建临床模型、影像组学模型及混合模型。影像组学模型平均AUC为0.847,混合模型为0.871,均显著优于临床模型(AUC 0.759),影像组学模型与混合模型间无显著差异。

要点

  • 影像组学模型预测T1期肺腺癌脑转移的平均AUC为0.847,敏感度80.0%、特异度81.5%。
  • 混合模型平均AUC为0.871,敏感度82.9%、特异度83.3%,与影像组学模型无显著差异(P=0.1022)。
  • 影像组学模型与混合模型均显著优于临床模型(P=0.0072和P=0.0492)。

核心结论

  • 基于平扫CT的影像组学模型对T1期肺腺癌脑转移表现出良好的预测性能,有较大潜力作为辅助工具指导脑转移筛查。

研究设计与样本

  • 研究纳入89例T1期肺腺癌患者,其中脑转移35例、无脑转移54例,从每例患者平扫CT图像提取1160个定量影像组学特征。
  • 建立临床模型、影像组学模型和混合(临床加影像组学)模型三种预测模型,采用ROC AUC值和10折交叉验证评估预测性能。

诊断标准与关键数值

  • 临床模型平均AUC为0.759(95%CI 0.643-0.867),敏感度82.9%、特异度57.4%。
  • 影像组学模型平均AUC为0.847(95%CI 0.739-0.915),敏感度80.0%、特异度81.5%。
  • 混合模型平均AUC为0.871(95%CI 0.767-0.933),敏感度82.9%、特异度83.3%。
  • 混合模型与影像组学模型分别显著优于临床模型(P=0.0072和P=0.0492),影像组学模型与混合模型间无显著差异(P=0.1022)。

临床应用与阅片要点

  • 作者认为基于平扫CT的影像组学模型作为有前景的辅助工具,可能有助于指导脑转移筛查,从而有利于肺癌患者的个体化监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study is to develop and evaluate an unenhanced CT-based radiomics model to predict brain metastasis (BM) in patients with category T1 lung adenocarcinoma. MATERIALS AND METHODS. A total of 89 eligible patients with category T1 lung adenocarcinoma were enrolled and classified as patients with BM (n = 35) or patients without BM (n = 54). A total of 1160 quantitative radiomic features were extracted from unenhanced CT images of each patient. Three prediction models (the clinical model, the radiomics model, and a hybrid [clinical plus radiomics] model) were established. The ROC AUC value and 10-fold cross-validation were used to evaluate the prediction performance of the models. RESULTS. In terms of predictive performance, the mean AUC value was 0.759 (95% CI, 0.643-0.867; sensitivity, 82.9%; specificity, 57.4%) for the clinical model, 0.847 (95% CI, 0.739-0.915; sensitivity, 80.0%; specificity, 81.5%) for the radiomics model, and 0.871 (95% CI, 0.767-0.933; sensitivity = 82.9%, specificity = 83.3%) for the hybrid model. The hybrid and radiomics models (p = 0.0072 and 0.0492, respectively) performed significantly better than the clinical model. No significant difference was found between the radiomics model and the hybrid model (p = 0.1022). CONCLUSION. A CT-based radiomics model presented good predictive performance and great potential for predicting BM in patients with category T1 lung adenocarcinoma. As a promising adjuvant tool, it can be helpful for guiding BM screening and thus benefiting personalized surveillance for patients with lung cancer.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Chen A, Lu L, Pu X, et al. CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma. AJR Am J Roentgenol. 2019. PMID: 30933649. doi:10.2214/AJR.18.20591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。